HOMER3 and breast cancer: Taken together, our findings suggest that HOMER3 provides a scaffold platform to promote Tyr phosphorylation and activation of β-Catenin, leading to the malignant progression and poor clinical outcomes in human breast cancer (Fig. 7d).